makethembroke - Turn competitor free‑trial credits into a revenue‑draining

What it is: makethembroke.com lets you select a competitor’s free‑trial offering and automatically consume their trial credits. Using anonymous Web3‑based payments and residential‑proxy botnets, the service spins up trial accounts, runs heavy compute or API calls, and drains the allocated resources without leaving any trace. Why it matters: Free‑trial plans are a major acquisition channel for SaaS companies but also represent a direct cost (GPU time, API usage, bandwidth). When bots consume those credits, the competitor’s infrastructure bill can explode, forcing them to rethink pricing, limits, or even abandon the free tier. makethembroke.com highlights this vulnerability and pushes the industry toward more sustainable, abuse‑resistant trial models. Key features: - Target selection – enter any domain (AI, design, dev tools, etc.) to start an automated credit‑draining campaign. - Anonymous checkout – no accounts, no email verification, no cookies. Payments processed via Web3 (Polygon, Base, Ethereum) for complete privacy. - Tiered execution: • Starter ($100‑$1K) – deploy residential‑proxy bots to exhaust basic API quotas (≈10× credit burn). • Pro ($1K‑$5K) – run concurrent high‑compute queries to bleed premium resource pools (≈15× credit burn). • Max ($5K+) – multi‑region automated loops that push infrastructure to its limits (≈25× credit burn). - Real‑time tracker – a cryptographic token lets you monitor credit depletion live. - Zero footprint – all operations run without storing personal data; no logs are left. How it works (4 steps): 1. Select a target – provide the competitor’s website or product name. 2. Choose a tier – pick the level of resource consumption you need. 3. Pay anonymously – complete checkout via a Web3 wallet; no KYC required. 4. Watch the drain – the platform launches bots, runs tasks, and updates your tracker token in real time. Who should use it: security researchers testing free‑trial limits; product managers assessing the cost impact of their own trial designs; growth hackers looking for a disruptive competitive edge; investors interested in the vulnerability of current PLG models.